请输入您要查询的百科知识:

 

词条 Posterior ischemic optic neuropathy
释义

  1. Signs and symptoms

     Ophthalmoscopic exam  Pupils  Arteritic PION  Perioperative PION 

  2. Cause

     Cardiovascular risk factors  Perioperative PION 

  3. Pathogenesis

     PION  A-PION   Perioperative PION  Intraoperative ischemic pressures 

  4. Diagnosis

      Differential diagnosis   Anterior ischemic optic neuropathy  PION versus AION  GCA 

  5. Prevention

  6. Treatment

     A-PION  Perioperative 

  7. Epidemiology

  8. References

  9. Further reading

  10. External links

{{Infobox medical condition (new)
| name = Posterior ischemic optic neuropath
|
| synonyms =
| symptoms =
| complications =
| onset =
| duration =
| types =
| causes =
| risks =
| diagnosis =
| differential =
| prevention =
| treatment =
| medication =
| prognosis =
| frequency =
| deaths =
}}

Posterior ischemic optic neuropathy (PION) is a medical condition characterized by damage to the retrobulbar portion of the optic nerve due to inadequate blood flow (ischemia) to the optic nerve. Despite the term posterior, this form of damage to the eye's optic nerve due to poor blood flow also includes cases where the cause of inadequate blood flow to the nerve is anterior, as the condition describes a particular mechanism of visual loss as much as the location of damage in the optic nerve. In contrast, anterior ischemic optic neuropathy (AION) is distinguished from PION by the fact that AION occurs spontaneously and on one side in affected individuals with predisposing anatomic or cardiovascular risk factors.{{citation needed|date=June 2014}}

{{TOC limit|3}}

Signs and symptoms

PION is characterized by moderate to severe painless vision loss of abrupt onset. One or both eyes may be affected and color vision is typically impaired.[1][1][2]

Ophthalmoscopic exam

Looking inside the person's eyes at the time of onset, ophthalmoscope exam reveals no visible changes to the optic nerve head. Weeks after ischemic insult, nerve atrophy originating from the damaged posterior optic nerve progresses to involve the anterior optic nerve head. Four to eight weeks after onset, atrophy of the optic nerve head is observable upon ophthalmoscope exam.[3]

Pupils

If both eyes are affected by PION, the pupils may look symmetrical. However, if the eyes are asymmetrically affected, i.e. one eye's optic nerve is more damaged than the other, it will produce an important sign called an afferent pupillary defect.{{citation needed|date=June 2014}}

Defective light perception in one eye causes an asymmetrical pupillary constriction reflex called the afferent pupillary defect (APD).{{citation needed|date=June 2014}}

Arteritic PION

A-PION most commonly affects Caucasian women, with an average age of 73.[1][4] At onset vision loss is unilateral, but without treatment it rapidly progresses to involve both eyes. Vision loss is usually severe, ranging from counting fingers to no light perception. Associated symptoms are jaw pain exacerbated by chewing, scalp tenderness, shoulder and hip pain, headache and fatigue.[2][3]

Perioperative PION

Vision loss is usually apparent upon waking from general anesthesia. Signs observable to a bystander include long surgery duration and facial swelling. Vision loss is usually bilateral and severe, ranging from counting fingers to no light perception.[1][1][2][3][5][6]{{synthesis inline|date=June 2014}}

Cause

PION is a watershed infarction of the optic nerve that may cause either unilateral or, more often, bilateral blindness. PION typically occurs in two categories of people:{{citation needed|date=June 2014}}

  • People who have undergone non-ocular surgery that is particularly prolonged or is associated with a significant blood loss.{{citation needed|date=June 2014}}
  • People who have experienced significant bleeding from an accident or ruptured blood vessels. In these cases, the person may develop anemia (too few oxygen-delivering red blood cells in the bloodstream) and often have low blood pressure as well. This combination can produce circulatory shock, and PION has sometimes been called shock-induced optic neuropathy.{{citation needed|date=June 2014}}

The combination of anemia and low blood pressure means that the blood is carrying less oxygen to the tissues. The optic nerve can be at very high risk for damage from insufficient blood supply due to swelling (from lack of oxygen) in a confined bony space resulting in a compartment syndrome. Restricted blood flow can lead to permanent damage to the optic nerve and result in blindness (often in both eyes). For technical reasons this occurs more frequently with spinal surgeries.[7]

Cardiovascular risk factors

Perioperative PION patients have a higher prevalence of cardiovascular risk factors than in the general population. Documented cardiovascular risks in people affected by perioperative PION include high blood pressure, diabetes mellitus, high levels of cholesterol in the blood, tobacco use, abnormal heart rhythms, stroke, and obesity. Men are also noted to be at higher risk, which is in accordance with the trend, as men are at higher risk of cardiovascular disease.[16][1][2][5][6][21][22][23][8] These cardiovascular risks all interfere with adequate blood flow, and also may suggest a contributory role of defective vascular autoregulation.[1][3][5][6]{{synthesis inline|date=June 2014}}

Perioperative PION

As illustrated by the risk factors above, perioperative hypoxia is a multifactorial problem. Amidst these risk factors it may be difficult to pinpoint the optic nerve’s threshold for cell death, and the exact contribution of each factor.[29]

Low blood pressure and anemia are cited as perioperative complications in nearly all reports of PION, which suggests a causal relationship. However, while low blood pressure and anemia are relatively common in the perioperative setting, PION is exceedingly rare. Spine and cardiac bypass surgeries have the highest estimated incidences of PION, 0.028% and 0.018% respectively, and this is still extremely low.[7][9][10] This evidence suggests that optic nerve injury in PION patients is caused by more than just anemia and low blood pressure.[29]

Evidence suggests that the multifactorial origin of perioperative PION involves the risks discussed above and perhaps other unknown factors. Current review articles of PION propose that vascular autoregulatory dysfunction and anatomic variation are under-investigated subjects that may contribute to patient-specific susceptibility.[3][5]

Pathogenesis

PION

In both types of PION, decreased blood flow leads to the death of optic nerve cells. Ischemic injury to the optic nerve causes inflammation and swelling. Because the posterior optic nerve passes through the optic canal, a bony tunnel leading to the brain, swelling in this rigid space causes compression of the optic nerve. This compression worsens ischemia and perpetuates the cycle of injury, and swelling, and compression.[1]

A-PION

A-PION is caused by an inflammatory disease called giant cell arteritis (GCA). GCA is an inflammatory disease of blood vessels. It is believed to be an autoimmune disease caused by inappropriate T-cell activity.[3][11] When T-cells damage arteries supplying the optic nerve, a blood clot forms and stops blood flow. When blood flow stops, oxygen delivery stops and optic nerve fibers die.{{citation needed|date=June 2014}}

Perioperative PION

The exact cause of perioperative PION is unknown. Many risk factors have been identified, all of which contribute to inadequate delivery of oxygen to optic nerve cells. Alone, none of these risk factors is enough to cause PION. However, in susceptible individuals, a combination of these risk factors produces devastating blindness. This evidence suggests that PION is a disease of multifactorial origin.{{citation needed|date=June 2014}}

Risks of perioperative PION can be divided into two categories, intraoperative ischemic pressures, and cardiovascular risk factors.{{citation needed|date=June 2014}}

Intraoperative ischemic pressures

Many causes of decreased blood flow during surgery are systemic, i.e. they decrease blood flow throughout the body. Studies have shown that nearly all perioperative PION patients suffered from prolonged periods of low blood pressure during the operation and postoperative anemia. The average perioperative PION patient loses 4 liters of blood during surgery, and the majority receive blood transfusions. Massive blood loss is just one cause of low blood pressure. Medications used for general anesthesia can also lower blood pressure. The average surgery duration in PION cases is 7 to 9 hours, which increases the risk of prolonged low blood pressure.[7][1][3][5]

Other intraoperative ischemic pressures are local, i.e. they decrease blood flow to the affected area, the optic nerve. Facial swelling, periorbital swelling, direct orbital compression, facedown position during surgery, and a tilted operating table in feet-above-head position, have all been reported to be associated with perioperative PION. All of these factors are believed to increase tissue pressure and venous pressure around the optic nerve, thereby decreasing local blood flow and oxygen delivery.[16][1][3][5][12][13][14][15]

Surgeries with the highest estimated incidence of PION are surgeries with a higher risk of the aforementioned conditions. In spine surgery, patients are susceptible to significant blood loss, and they are positioned face down for long periods of time, which increases venous pressure, decreases arterial perfusion pressure, and often causes facial swelling (increased tissue pressure). Spine surgery is estimated to have the highest incidence of PION, 0.028%.[7] Long duration of feet-above-head position in prostate surgery has also been suggested to increase risk of PION.[16]

Diagnosis

The diagnosis of PION is often difficult since the optic nerves initially appear normal. The injury occurs posterior to that portion of the nerve visible during ophthalmoscopic examination. There may be an abnormal relative pupillary response (APD) if the injury is confined to one optic nerve, but often it is bilateral and the symmetry of pupillary responses is maintained. Furthermore, MRI scanning may not be helpful. It is not uncommon for the erroneous diagnoses of malingering or cortical blindness to be made. If possible, an urgent neuro-ophthalmology consult is most likely to lead to the correct diagnosis.[17]

There is no confirmatory test for PION. PION is a diagnosis of exclusion. To prevent impending blindness, it is urgent to rule out giant cell arteritis when a patient over 50 presents with sudden vision loss.{{citation needed|date=June 2014}}

Differential diagnosis

In the postoperative setting, without gross eye injury, visual loss requires an assessment of the whole visual system for ischemic damage. The optic nerve is not the only tissue of the visual pathway susceptible to decreased blood flow. Decreased oxygenation of the retina or brain could also impair vision.[17]

Anterior ischemic optic neuropathy

PION is less common than Anterior Ischemic Optic Neuropathy (AION).[3] Blood supply and surrounding anatomy make the anterior and posterior portions of the optic nerve susceptible to different ischemic pressures.{{citation needed|date=June 2014}}

The posterior optic nerve receives blood primarily from the pial branches of the ophthalmic artery. The optic canal, a boney tunnel leading to the brain, surrounds the most posterior part of this optic nerve segment.{{citation needed|date=June 2014}}

The anterior optic nerve receives blood primarily from the posterior ciliary arteries. The anterior optic nerve, a.k.a. the optic nerve head, is surrounded by the scleral canal, and is vulnerable to crowding of nerve fibers. The portion of the optic nerve head that is visible by looking into the eye with an ophthalmoscope is called the optic disc.{{citation needed|date=June 2014}}

PION versus AION

At the onset of symptoms, ophthalmoscope examination can differentiate AION from PION. If optic nerve head involvement is observed, it is AION. PION does not produce optic atrophy that is observable via ophthalmoscope until four to eight weeks after onset. In addition, AION often shows a characteristic altitudinal defect on a Humphrey Visual Field test.{{citation needed|date=June 2014}}

GCA

The American College of Rheumatology has defined a combination of physical symptoms and inflammatory changes to diagnose giant cell arteritis.[18]

Prevention

Individuals with a history of high blood pressure, diabetes, and smoking are most susceptible to PION as they have a compromised system of blood vessel autoregulation. Hence, extra efforts may need to be taken for them in the form of careful or staged surgery or the controlling the anemia from blood loss (by administration of blood transfusions), and the careful maintenance of their blood pressure.[19]

Treatment

Once visual loss has occurred, it becomes more problematic, but there are reports of recovered vision if blood transfusions and agents that raise blood pressure are administered within hours.[20]

A-PION

If a diagnosis of GCA is suspected, treatment with steroids should begin immediately. A sample (biopsy) of the temporal artery should be obtained to confirm the diagnosis and guide future management, but should not delay initiation of treatment. Treatment does not recover lost vision, but prevents further progression and second eye involvement. High dose corticosteroids may be tapered down to low doses over approximately one year.[1][2][5][14][21][22][23][24]{{synthesis inline|date=June 2014}}

Perioperative

Rapid blood transfusions, to correct anemia and raise blood pressure, may improve PION outcomes. In one report of a related disease, hypotension-induced AION, 3 out of 3 patients who received rapid transfusions reported partial recovery of vision.[20] While rapid transfusions offer some hope, the prognosis for perioperative PION remains poor. Prevention remains the best way to reduce PION.

One retrospective report proposes that incidence of PION could be reduced in high-risk cases by altering surgical management. For example, for patients undergoing spine surgery, measures could be taken to minimize intraoperative hypotension, to accelerate the process of blood replacement, and to aggressively treat facial swelling.[19]

Epidemiology

PION most commonly affects the elderly.{{citation needed|date=September 2017}}

References

1. ^{{cite journal |author=Hayreh SS |title=Posterior ischaemic optic neuropathy: clinical features, pathogenesis, and management |journal=Eye |volume=18 |issue=11 |pages=1188–206 |date=November 2004 |pmid=15534605 |doi=10.1038/sj.eye.6701562}}
2. ^{{cite journal |vauthors=Sadda SR, Nee M, Miller NR, Biousse V, Newman NJ, Kouzis A |title=Clinical spectrum of posterior ischemic optic neuropathy |journal=American Journal of Ophthalmology |volume=132 |issue=5 |pages=743–50 |date=November 2001 |pmid=11704036 |doi=10.1016/S0002-9394(01)01199-0}}
3. ^{{cite journal |author=Hayreh SS |title=Ischemic optic neuropathy |journal=Progress in Retinal and Eye Research |volume=28 |issue=1 |pages=34–62 |date=January 2009 |pmid=19063989 |doi=10.1016/j.preteyeres.2008.11.002}}
4. ^{{cite journal |vauthors=Hayreh SS, Podhajsky PA, Zimmerman B |title=Ocular manifestations of giant cell arteritis |journal=American Journal of Ophthalmology |volume=125 |issue=4 |pages=509–20 |date=April 1998 |pmid=9559737 |doi=10.1016/s0002-9394(99)80192-5}}
5. ^{{cite journal |vauthors=Buono LM, Foroozan R |title=Perioperative posterior ischemic optic neuropathy: review of the literature |journal=Survey of Ophthalmology |volume=50 |issue=1 |pages=15–26 |year=2005 |pmid=15621075 |doi=10.1016/j.survophthal.2004.10.005}}
6. ^{{cite journal |vauthors=Lee LA, Roth S, Posner KL, etal |title=The American Society of Anesthesiologists Postoperative Visual Loss Registry: analysis of 93 spine surgery cases with postoperative visual loss |journal=Anesthesiology |volume=105 |issue=4 |pages=652–9; quiz 867–8 |date=October 2006 |pmid=17006060 |url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0003-3022&volume=105&issue=4&spage=652 |doi=10.1097/00000542-200610000-00007}}
7. ^{{cite journal |vauthors=Chang SH, Miller NR |title=The incidence of vision loss due to perioperative ischemic optic neuropathy associated with spine surgery: the Johns Hopkins Hospital Experience |journal=Spine |volume=30 |issue=11 |pages=1299–302 |date=June 2005 |pmid=15928556 |url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0362-2436&volume=30&issue=11&spage=1299 |doi=10.1097/01.brs.0000163884.11476.25}}
8. ^{{cite journal |vauthors=Pazos GA, Leonard DW, Blice J, Thompson DH |title=Blindness after bilateral neck dissection: case report and review |journal=American Journal of Otolaryngology |volume=20 |issue=5 |pages=340–5 |year=1999 |pmid=10512147 |doi=10.1016/S0196-0709(99)90039-X}}
9. ^{{cite journal |vauthors=Stevens WR, Glazer PA, Kelley SD, Lietman TM, Bradford DS |title=Ophthalmic complications after spinal surgery |journal=Spine |volume=22 |issue=12 |pages=1319–24 |date=June 1997 |pmid=9201834 |url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0362-2436&volume=22&issue=12&spage=1319 |doi=10.1097/00007632-199706150-00008}}
10. ^{{cite journal |vauthors=Sweeney PJ, Breuer AC, Selhorst JB, etal |title=Ischemic optic neuropathy: a complication of cardiopulmonary bypass surgery |journal=Neurology |volume=32 |issue=5 |pages=560–2 |date=May 1982 |pmid=7200214 |doi=10.1212/wnl.32.5.560}}
11. ^{{cite journal |vauthors=Weyand CM, Goronzy JJ |title=Medium- and large-vessel vasculitis |journal=The New England Journal of Medicine |volume=349 |issue=2 |pages=160–9 |date=July 2003 |pmid=12853590 |doi=10.1056/NEJMra022694}}
12. ^{{cite journal |vauthors=Ho VT, Newman NJ, Song S, Ksiazek S, Roth S |title=Ischemic optic neuropathy following spine surgery |journal=Journal of Neurosurgical Anesthesiology |volume=17 |issue=1 |pages=38–44 |date=January 2005 |pmid=15632541 |pmc=2699455 |url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0898-4921&volume=17&issue=1&spage=38}}
13. ^{{cite journal |vauthors=Alexandrakis G, Lam BL |title=Bilateral posterior ischemic optic neuropathy after spinal surgery |journal=American Journal of Ophthalmology |volume=127 |issue=3 |pages=354–5 |date=March 1999 |pmid=10088754 |doi=10.1016/S0002-9394(98)00343-2}}
14. ^{{cite journal |vauthors=Gill B, Heavner JE |title=Postoperative visual loss associated with spine surgery |journal=European Spine Journal |volume=15 |issue=4 |pages=479–84 |date=April 2006 |pmid=15926057 |pmc=3489312 |doi=10.1007/s00586-005-0914-6}}
15. ^{{cite journal |vauthors=Myers MA, Hamilton SR, Bogosian AJ, Smith CH, Wagner TA |title=Visual loss as a complication of spine surgery. A review of 37 cases |journal=Spine |volume=22 |issue=12 |pages=1325–9 |date=June 1997 |pmid=9201835 |url=http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?issn=0362-2436&volume=22&issue=12&spage=1325 |doi=10.1097/00007632-199706150-00009}}
16. ^{{cite journal |vauthors=Weber ED, Colyer MH, Lesser RL, Subramanian PS |title=Posterior ischemic optic neuropathy after minimally invasive prostatectomy |journal=Journal of Neuro-Ophthalmology |volume=27 |issue=4 |pages=285–7 |date=December 2007 |pmid=18090562 |doi=10.1097/WNO.0b013e31815b9f67}}
17. ^{{cite journal |author=Newman NJ |title=Perioperative visual loss after nonocular surgeries |journal=American Journal of Ophthalmology |volume=145 |issue=4 |pages=604–610 |date=April 2008 |pmid=18358851 |pmc=2989384 |doi=10.1016/j.ajo.2007.09.016}}
18. ^{{cite journal |vauthors=Hunder GG, Bloch DA, Michel BA, etal |title=The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis |journal=Arthritis and Rheumatism |volume=33 |issue=8 |pages=1122–8 |date=August 1990 |doi=10.1002/art.1780330810 |pmid=2202311}}
19. ^{{cite journal |vauthors=Dunker S, Hsu HY, Sebag J, Sadun AA |title=Perioperative risk factors for posterior ischemic optic neuropathy |journal=Journal of the American College of Surgeons |volume=194 |issue=6 |pages=705–10 |date=June 2002 |pmid=12081060 |doi=10.1016/S1072-7515(02)01210-3}}
20. ^{{cite journal |vauthors=Connolly SE, Gordon KB, Horton JC |title=Salvage of vision after hypotension-induced ischemic optic neuropathy |journal=American Journal of Ophthalmology |volume=117 |issue=2 |pages=235–42 |date=February 1994 |pmid=8116753|doi=10.1016/s0002-9394(14)73082-x}}
21. ^{{cite journal |vauthors=Salvarani C, Macchioni PL, Tartoni PL, etal |title=Polymyalgia rheumatica and giant cell arteritis: a 5-year epidemiologic and clinical study in Reggio Emilia, Italy |journal=Clinical and Experimental Rheumatology |volume=5 |issue=3 |pages=205–15 |year=1987 |pmid=3501353}}
22. ^{{cite journal |vauthors=Delecoeuillerie G, Joly P, Cohen de Lara A, Paolaggi JB |title=Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11 year survey of 210 patients) |journal=Annals of the Rheumatic Diseases |volume=47 |issue=9 |pages=733–9 |date=September 1988 |pmid=3178314 |pmc=1003589 |url=http://ard.bmj.com/cgi/pmidlookup?view=long&pmid=3178314 |doi=10.1136/ard.47.9.733}}
23. ^{{cite journal |vauthors=Lundberg I, Hedfors E |title=Restricted dose and duration of corticosteroid treatment in patients with polymyalgia rheumatica and temporal arteritis |journal=The Journal of Rheumatology |volume=17 |issue=10 |pages=1340–5 |date=October 1990 |pmid=2254893}}
24. ^{{cite journal |vauthors=Foroozan R, Deramo VA, Buono LM, etal |title=Recovery of visual function in patients with biopsy-proven giant cell arteritis |journal=Ophthalmology |volume=110 |issue=3 |pages=539–42 |date=March 2003 |pmid=12623817 |doi=10.1016/S0161-6420(02)01775-X}}

Further reading

  • {{cite journal |vauthors=Luneau K, Newman NJ, Biousse V |title=Ischemic optic neuropathies |journal=The Neurologist |volume=14 |issue=6 |pages=341–54 |date=November 2008 |pmid=19008740 |doi=10.1097/NRL.0b013e318177394b}}
  • {{cite journal |vauthors=Remigio D, Wertenbaker C |title=Post-operative bilateral vision loss |journal=Survey of Ophthalmology |volume=44 |issue=5 |pages=426–32 |year=2000 |pmid=10734242 |doi=10.1016/S0039-6257(00)00107-7}}
  • {{cite journal |vauthors=Buono LM, Foroozan R, Savino PJ, Danesh-Meyer HV, Stanescu D |title=Posterior ischemic optic neuropathy after hemodialysis |journal=Ophthalmology |volume=110 |issue=6 |pages=1216–8 |date=June 2003 |pmid=12799249 |doi=10.1016/S0161-6420(03)00257-4}}

External links

{{Medical resources
| ICD10 = {{ICD10|H|47|0|h|46}}
| ICD9 = {{ICD9|377.41}}
| MeshID = D018917
}}{{Eye pathology}}{{DEFAULTSORT:Posterior Ischemic Optic Neuropathy}}

1 : Diseases of the eye and adnexa

随便看

 

开放百科全书收录14589846条英语、德语、日语等多语种百科知识,基本涵盖了大多数领域的百科知识,是一部内容自由、开放的电子版国际百科全书。

 

Copyright © 2023 OENC.NET All Rights Reserved
京ICP备2021023879号 更新时间:2024/9/30 3:36:38